Rainbow Childrens Medicare
add_icon

Rainbow Childrens Medicare

1,188.20
-0.30
(-0.03%)
Market Cap
12,067.26 Cr
PE Ratio
47.29
Volume
1,20,429.00
Day High - Low
1,198.50 - 1,166.00
52W High-Low
1,645.70 - 1,154.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
12,067.26 Cr
EPS
23.97
PE Ratio
47.29
PB Ratio
7.94
Book Value
149.46
EBITDA
540.90
Dividend Yield
0.25 %
Sector
Hospitals
Return on Equity
16.56
Debt to Equity
0.56
Analyst Rating and Forecast
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+88.89 %
+88.89 %
Hold
Hold+11.11 %
+11.11 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Rainbow Children's Medicare Limited's Nomination and Remuneration Committee approved the grant of 1,00,000 stock options under ESOP 2025 to eligible employees on January 28, 2026.
positive
Rainbow Childrens Medicare reported consolidated net profit of ₹725 million in Q3, marking a 5.5% increase from ₹687 million in the corresponding quarter of the previous year.
positive
Rainbow Children's Medicare expands its presence in Bengaluru with the launch of a new 90-bed healthcare facility in Electronic City, strengthening its footprint in Karnataka's capital city.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
6,877.50
#1 98,887.90
56.51
#1 21,994.30
14.76
#1 1,505
24.84
38.45
958.60
93,249.67
69.92
7,184.10
#1 28.65
1,076
#1 74.34
26.55
849.05
64,099.72
60.93
7,849.70
13.25
809
70.27
37.57
1,761.60
36,000.20
#1 41.74
5,575.00
12.29
790
30.03
37.84
549.65
28,478.52
78.73
4,286.70
15.12
337
14.65
31.27
1,049.00
28,196.11
49.86
3,771.40
12.59
481
21.10
33.35
609.65
24,394.47
69.13
3,067.00
21.98
415
-40.35
44.93
439.45
13,907.27
97.19
1,757.00
27.64
110
71.36
19.97
1,188.20
#9 12,067.26
#3 47.29
#9 1,566.90
#5 17.46
#8 244
#9 -4.30
24.17
1,305.80
8,561.61
43.60
1,290.20
17.77
194
11.00
32.97
Growth Rate
Revenue Growth
17.46 %
Net Income Growth
11.86 %
Cash Flow Change
23.11 %
ROE
-4.06 %
ROCE
3.26 %
EBITDA Margin (Avg.)
-1.17 %

Quarterly Financial Results

Quarterly Financials
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
166
249
271
255
219
243
321
315
326
295
341
345
354
342
429
411
385
373
453
456
Expenses
132
168
177
160
164
155
204
200
219
200
215
218
236
237
270
264
255
249
296
299
EBITDA
34
80
94
95
54
88
117
115
107
96
125
127
118
106
158
148
129
124
157
158
Operating Profit %
20 %
32 %
34 %
36 %
23 %
35 %
35 %
35 %
31 %
31 %
35 %
35 %
31 %
28 %
35 %
34 %
31 %
29 %
33 %
33 %
Depreciation
20
19
21
21
22
22
23
23
23
25
27
28
32
34
35
35
34
34
36
40
Interest
13
13
12
12
16
14
13
14
14
15
13
14
17
18
18
18
18
18
19
20
Profit Before Tax
2
48
61
62
16
52
81
78
70
56
85
85
69
53
105
94
77
71
102
98
Tax
1
12
16
17
4
13
20
20
16
14
22
22
18
14
26
25
20
18
27
24
Net Profit
1
36
45
45
12
39
62
58
54
42
63
63
51
40
79
69
57
54
76
74
EPS in ₹
0.14
3.91
4.87
4.79
1.36
3.78
6.06
5.74
5.31
4.04
6.20
6.12
5.02
3.89
7.77
6.76
5.55
5.27
7.41
7.14

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
231
349
399
448
926
1,019
1,081
1,296
1,776
2,170
2,377
Fixed Assets
78
123
174
296
702
702
772
858
931
1,253
1,398
Current Assets
98
171
125
73
133
203
197
290
484
622
822
Capital Work in Progress
35
31
7
12
23
43
29
6
23
20
29
Investments
7
2
6
0
3
10
18
22
58
308
571
Other Assets
111
194
212
140
199
265
262
409
764
590
380
Total Liabilities
231
349
399
448
926
1,019
1,081
1,296
1,776
2,170
2,377
Current Liabilities
36
42
56
71
92
130
122
125
144
150
151
Non Current Liabilities
15
13
14
15
463
480
511
564
567
756
751
Total Equity
181
295
329
362
372
409
448
606
1,065
1,265
1,475
Reserve & Surplus
166
275
309
307
317
351
392
498
958
1,157
1,367
Share Capital
15
20
20
55
55
55
55
105
102
102
102

Cash Flow

Cash Flow
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-1
3
1
-2
2
2
-1
4
5
-7
10
Investing Activities
-113
-20
-107
-33
-42
-117
-117
-83
-175
-465
-227
-268
Operating Activities
15
26
17
36
48
127
170
143
224
327
321
396
Financing Activities
98
-7
93
-1
-8
-9
-52
-61
-44
143
-102
-118

Share Holding

% Holding
Dec 2021
May 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
63.70 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.88 %
49.85 %
49.85 %
49.85 %
49.85 %
49.85 %
49.84 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
21.63 %
22.32 %
24.04 %
24.78 %
25.11 %
25.12 %
23.69 %
23.59 %
21.85 %
19.23 %
DIIs
0.00 %
6.35 %
6.55 %
10.26 %
13.90 %
15.38 %
15.35 %
15.40 %
15.62 %
14.76 %
13.80 %
13.83 %
13.87 %
15.31 %
15.44 %
17.46 %
19.49 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
19.03 %
15.87 %
13.24 %
13.75 %
13.29 %
13.04 %
11.92 %
11.03 %
10.40 %
10.74 %
10.40 %
10.38 %
10.34 %
10.32 %
10.06 %
10.49 %
Others
36.30 %
24.79 %
27.75 %
26.67 %
22.52 %
21.50 %
21.78 %
1.22 %
1.21 %
0.97 %
0.80 %
0.80 %
0.77 %
0.79 %
0.79 %
0.78 %
0.95 %
No of Share Holders
146
2,43,189
1,66,064
91,530
79,224
75,611
74,690
79,187
80,471
77,152
78,557
77,524
78,764
79,092
80,320
81,134
88,809

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 2 3 3 3 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.28 0.23 0.21 0.25 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2026 1,209.80 1,186.90
08 Sept 2022 DIVIDEND Dividend
₹ 2.00 /share
07 Sept 2022 489.05 611.60
22 Jun 2023 DIVIDEND Dividend
₹ 3.00 /share
22 Jun 2023 849.65 977.25
23 Jul 2024 DIVIDEND Dividend
₹ 3.00 /share
23 Jul 2024 1,393.75 1,145.75
30 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jul 2024 1,393.75 1,172.30
27 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Oct 2024 1,431.30 1,417.75
09 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Feb 2025 1,423.75 1,383.95
24 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 May 2025 1,366.75 1,352.30
28 Jun 2025 DIVIDEND Dividend
₹ 3.00 /share
27 Jun 2025 1,352.30 1,512.95
05 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Jul 2025 1,352.30 1,599.40
26 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 Jul 2025 1,526.50 1,554.50
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 1,363.70 1,359.10

Announcements

Announcement under Regulation 30 (LODR)-Investor Presentation9 hrs ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release9 hrs ago
Grant Of Stock Options9 hrs ago
Unaudited Financial Results For Quarter And Nine Months Ended December 31 20259 hrs ago
Board Meeting Outcome for Outcome For The Board Meeting Held On January 28 202610 hrs ago
Commencement Of A New Spoke Hospital In Electronic City Bengaluru.15 hrs ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
Board Meeting Intimation for Approval Of Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.7 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2026
Closure of Trading WindowDec 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 03, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 13, 2025
Grant Of Stock OptionsNov 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 13, 2025
Unaudited Financial Results Quarter And Half Year Ended September 30 2025Nov 13, 2025
Board Meeting Outcome for Outcome For The Board Meeting Held On November 13 2025Nov 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 08, 2025
Board Meeting Intimation for Approval Of Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025.Nov 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 29, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 13, 2025
Commencement Of A New Spoke Hospital In Rajahmundry Andhra Pradesh.Sep 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotAug 28, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionAug 18, 2025
Announcement under Regulation 30 (LODR)-Credit RatingAug 14, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 12, 2025
Announcement under Regulation 30 (LODR)-AcquisitionAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 26, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 26, 2025
Grant Of Stock OptionsJul 26, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 26, 2025
Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On July 26 2025Jul 26, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025Jul 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 22, 2025
Board Meeting Intimation for Approval Of Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter Ended June 30 2025.Jul 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 07, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 05, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJul 01, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJun 28, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Helios Mid Cap Fund Direct-Growth
1.44%
75685
0.34%
0.94%
UTI Multi Cap Fund Direct-Growth
0.99%
30438
0.16%
0.17%
Helios Small Cap Fund Direct-Growth
1.43%
12992
-0.09%
1.43%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
3.15%
10000
0.28%
0.28%
Bandhan Healthcare Fund Direct - Growth
2.00%
5000
0.15%
2.00%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.33%
866
-0.01%
0.00%
DSP Nifty Smallcap 250 Index Fund Direct - Growth
0.33%
192
0.33%
0.33%
Navi Nifty MidSmallcap 400 Index Fund Direct - Growth
0.11%
95
0.11%
0.11%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.03%
3
0.00%
0.00%
Kotak Healthcare Fund Direct - Growth
1.27%
0
0.00%
-0.04%
Tata Retirement Savings Fund Moderate Plan Direct-Growth
1.69%
0
0.00%
-0.03%
Axis Services Opportunities Fund Direct - Growth
1.01%
0
0.04%
0.04%
Axis Small Cap Fund Direct-Growth
0.42%
0
0.00%
-0.01%
Bajaj Finserv Healthcare Fund Direct-Growth
1.19%
0
0.00%
0.01%
Bandhan Aggressive Hybrid Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Balanced Advantage Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.49%
0
0.00%
0.00%
Bandhan Flexi Cap Fund Direct-Growth
0.51%
0
0.00%
-0.01%
Bandhan Focused Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Multi Asset Allocation Fund Direct-Growth
0.29%
0
0.00%
-0.03%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.33%
0
0.00%
-0.01%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.03%
0
0.00%
0.00%
Bandhan Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Conservative Hybrid Fund Direct-Growth
0.28%
0
0.00%
0.00%
Baroda BNP Paribas ELSS Tax Saver Fund Direct-Growth
1.41%
0
0.00%
-0.02%

Technical Indicators

RSI(14)
Neutral
24.22
ATR(14)
Volatile
31.72
STOCH(9,6)
Oversold
14.24
STOCH RSI(14)
Oversold
18.02
MACD(12,26)
Bearish
-8.80
ADX(14)
Strong Trend
38.21
UO(9)
Bearish
40.43
ROC(12)
Downtrend And Accelerating
-7.89
WillR(14)
Oversold
-80.18

About Rainbow Childrens Medicare

Rainbow Children's Medicare Limited is a leading chain of multi-specialty pediatric, obstetrics, and gynecology hospitals in India. Originally incorporated in 1998, it operates 16 hospitals and three clinics across six cities, with a total bed capacity of 1,655. The company specializes in pediatric services, including newborn and pediatric intensive care,...more
Listing Date
10 May, 2022(3 Years, 50 days)
Chairperson NameRamesh Kancharla